RhumbLine Advisers’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$383K Buy
67,505
+65,651
+3,541% +$373K ﹤0.01% 2849
2025
Q1
$8.83K Hold
1,854
﹤0.01% 3849
2024
Q4
$10.3K Hold
1,854
﹤0.01% 3880
2024
Q3
$11.7K Buy
1,854
+1,800
+3,333% +$11.4K ﹤0.01% 3871
2024
Q2
$228 Sell
54
-4
-7% -$17 ﹤0.01% 4317
2024
Q1
$420 Hold
58
﹤0.01% 4195
2023
Q4
$290 Hold
58
﹤0.01% 4222
2023
Q3
$243 Hold
58
﹤0.01% 4262
2023
Q2
$233 Buy
+58
New +$233 ﹤0.01% 4352
2021
Q2
Sell
-3,595
Closed -$169K 2981
2021
Q1
$169K Hold
3,595
﹤0.01% 2866
2020
Q4
$141K Buy
3,595
+612
+21% +$24K ﹤0.01% 2910
2020
Q3
$76K Sell
2,983
-573
-16% -$14.6K ﹤0.01% 2914
2020
Q2
$259K Buy
3,556
+705
+25% +$51.3K ﹤0.01% 2644
2020
Q1
$150K Buy
2,851
+750
+36% +$39.5K ﹤0.01% 2674
2019
Q4
$172K Buy
2,101
+67
+3% +$5.49K ﹤0.01% 2786
2019
Q3
$115K Buy
2,034
+168
+9% +$9.5K ﹤0.01% 2862
2019
Q2
$223K Buy
1,866
+243
+15% +$29K ﹤0.01% 2745
2019
Q1
$299K Sell
1,623
-43
-3% -$7.92K ﹤0.01% 2555
2018
Q4
$297K Buy
1,666
+532
+47% +$94.8K ﹤0.01% 2548
2018
Q3
$363K Sell
1,134
-56
-5% -$17.9K ﹤0.01% 2419
2018
Q2
$476K Buy
1,190
+70
+6% +$28K ﹤0.01% 2326
2018
Q1
$402K Buy
1,120
+53
+5% +$19K ﹤0.01% 2298
2017
Q4
$423K Sell
1,067
-119
-10% -$47.2K ﹤0.01% 2304
2017
Q3
$505K Buy
1,186
+1
+0.1% +$426 ﹤0.01% 2301
2017
Q2
$190K Buy
+1,185
New +$190K ﹤0.01% 2778
2016
Q2
Sell
-491
Closed -$31K 2983
2016
Q1
$31K Hold
491
﹤0.01% 2976
2015
Q4
$41K Buy
+491
New +$41K ﹤0.01% 3008